| Revenue | DKK -286K | -56% |
| EBITDA | DKK -639K | +2% |
| Net profit | DKK -1,2M | -85% |
| Total assets | DKK 804K | -47% |
| Equity | DKK -544K | -186% |
| Employees | 1 | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -175 | -92 | -57 | -6 | 50 | 22 | -107 | 4 | 89 | 675 | -652 | -286 |
| Staff expenses | -31 | -0 | -0 | -0 | -0 | -78 | -50 | -0 | -25 | -171 | -3 | -354 |
| EBITDA | -206 | -92 | -57 | -6 | 50 | -55 | -159 | 4 | 65 | 504 | -655 | -639 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -382 | -353 | -173 | -173 | -239 | -193 | -211 | -336 |
| EBIT | -206 | -92 | -57 | -6 | -333 | -408 | -332 | -168 | -174 | 311 | -866 | -976 |
| Net financials | -75 | -220 | -241 | -113 | -751 | -286 | -2.009 | -18 | -15 | -8 | 49 | -32 |
| Profit before tax | -281 | -311 | -298 | -119 | -1.084 | -694 | -2.264 | -186 | -189 | 304 | -818 | -1.004 |
| Tax | -0 | -135 | -67 | -97 | -132 | -24 | -53 | -5 | -23 | 93 | -182 | 169 |
| Net profit | -281 | -176 | -232 | -22 | -951 | -670 | -2.211 | -181 | -166 | 210 | -635 | -1.173 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.692 | 2.997 | 3.382 | 4.048 | 3.256 | 2.862 | 930 | 851 | 1.345 | 1.375 | 1.521 | 804 |
| Equity | -39 | -171 | -143 | 34 | -917 | -1.387 | 402 | 220 | 54 | 264 | 629 | -544 |
| Long-term debt | 1.612 | 2.834 | 3.274 | 3.561 | 3.822 | 3.933 | 52 | 203 | 247 | 134 | 0 | 500 |
| Short-term debt | 120 | 155 | 51 | 283 | 314 | 263 | 465 | 421 | 1.044 | 963 | 892 | 848 |
| Total debt | 1.731 | 2.988 | 3.324 | 3.845 | 4.136 | 4.196 | 517 | 625 | 1.291 | 1.097 | 892 | 1.348 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LM Management | Management | 2011 | — | — |
CF Management | Management | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2011 | — | — | |
| Chairman | 2014 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
EXIMA HOLDING ApS | Company | 50.0% | 50.0% | 2022 |
PHARMPROTECH HOLDING ApS | Company | 10.0% | 10.0% | 2017 |
SØREN DAHLGAARD INVEST ApS | Company | 10.0% | 10.0% | 2022 |
THOMAS BOEL SIGURDSSON HOLDING ApS | Company | 15.0% | 15.0% | 2017 |
| Individual | 5.0% | 5.0% | 2014 | |
Greenwise Invest ApS | Company | 10.0% | 10.0% | 2022 |
| Individual | 5.0% | 5.0% | 2018 |
| Person | Role here | Other companies |
|---|---|---|
| Lars Munkøe | Management | 0 companies |
| Christian Fridberg | Management | 0 companies |
| Christian Bjerre Bojsen | Chairman | 0 companies |
| Morten Bitsch Janik | Chairman | 0 companies |
| Anders Jørn Knutsen | Chairman | 0 companies |
| Thomas Boel Sigurdsson | Board of Directors | 0 companies |